Adrenergic Control of P2Y6 Receptor-Dependent Phagocytosis in Rodent and Human Microglia

Thomas Deluc1,2, Ariel Ase1,2, Marie-France Dorion1

  • 1Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.

Glia
|July 16, 2025
PubMed

Insights

Microglia

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are central nervous system immune cells that respond to neuronal danger signals via purinergic receptors.
  • The P2Y6 receptor on microglia is crucial for phagocytosis, a process often dysregulated in neurodegenerative diseases and chronic pain.
  • Mechanisms modulating P2Y6 receptor activity are not fully understood.

Purpose of the Study:

  • To investigate the modulatory role of the microglial β2 adrenergic receptor (ADRB2) on P2Y6 receptor function.
  • To determine if ADRB2 signaling impacts P2Y6-mediated microglial phagocytosis and gene expression.

Main Methods:

  • Calcium imaging in primary mouse microglia and human iPSC-derived microglia.
  • Pharmacological activation and antagonism of ADRB2.
  • Assessment of microglial phagocytotic activity.
  • Quantitative analysis of P2Y6 mRNA expression.

Main Results:

  • ADRB2 activation by isoproterenol inhibited P2Y6-evoked calcium transients in microglia.
  • This inhibition was reversed by the ADRB2 antagonist ICI-118551 and conserved in human microglia.
  • ADRB2 signaling reduced P2Y6-induced phagocytosis in both mouse and human microglia.
  • ADRB2 activation led to decreased P2Y6 mRNA expression.

Conclusions:

  • ADRB2 signaling functionally and transcriptionally modulates P2Y6 receptor activity in microglia.
  • This crosstalk between adrenergic and purinergic signaling influences microglial responses.
  • These findings offer insights into the pathophysiology of neuro-immune disorders and chronic pain.

Related Concept Videos

GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...